We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals
CRBP

88 hedge funds and large institutions have $150M invested in Corbus Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

286% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 7

106% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 16

38% more capital invested

Capital invested by funds: $109M → $150M (+$41.1M)

28% more funds holding

Funds holding: 69 → 88 (+19)

0.27% more ownership

Funds ownership: 1.01% → 1.28% (+0.27%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

81% less call options, than puts

Call options by funds: $263K | Put options by funds: $1.4M

Holders
88
Holders Change
+19
Holders Change %
+27.54%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
33
Reduced
16
Closed
7
Calls
$263K
Puts
$1.4M
Net Calls
-$1.13M
Net Calls Change
-$339K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.63M
2
BlackRock
BlackRock
New York
+$7.11M
3
BBA
Baker Bros. Advisors
New York
+$4.71M
4
GPP
Great Point Partners
Connecticut
+$4.28M
5
Morgan Stanley
Morgan Stanley
New York
+$3.31M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.11M
2
PA
Perceptive Advisors
New York
-$1.53M
3
AA
ALPS Advisors
Colorado
-$354K
4
GCP
GSA Capital Partners
United Kingdom
-$245K
5
NFA
Nationwide Fund Advisors
Ohio
-$179K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$688K +$161K +752 +30%
TA
27
Teachers Advisors
New York
$599K – – –
CS
28
Credit Suisse
Switzerland
$562K +$357K +1,670 +173%
Wells Fargo
29
Wells Fargo
California
$556K +$182K +849 +48%
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$542K +$33.4K +156 +7%
WC
31
Woodstock Corp
Massachusetts
$511K – – –
T. Rowe Price Associates
32
T. Rowe Price Associates
Maryland
$482K +$359K +1,677 +287%
GCP
33
GSA Capital Partners
United Kingdom
$472K -$245K -1,143 -34%
Group One Trading
34
Group One Trading
Illinois
$465K +$155K +724 +50%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$346K +$125K +584 +56%
VEA
36
Virtus ETF Advisers
New York
$337K -$60.6K -283 -15%
VFA
37
Virtus Fund Advisers
Connecticut
$337K +$338K +1,581 New
Manulife (Manufacturers Life Insurance)
38
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$270K +$21.4K +100 +9%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$263K -$61.4K -287 -19%
ProShare Advisors
40
ProShare Advisors
Maryland
$261K +$262K +1,225 New
AIG
41
American International Group
New York
$232K +$21K +98 +10%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$227K – – –
Squarepoint
43
Squarepoint
New York
$221K +$222K +1,038 New
Goldman Sachs
44
Goldman Sachs
New York
$219K +$220K +1,030 New
AQR Capital Management
45
AQR Capital Management
Connecticut
$194K -$149K -696 -43%
Cambridge Investment Research Advisors
46
Cambridge Investment Research Advisors
Iowa
$191K +$2.14K +10 +1%
MIM
47
MetLife Investment Management
New Jersey
$164K +$165K +770 New
Citigroup
48
Citigroup
New York
$158K +$140K +656 +772%
VOYA Investment Management
49
VOYA Investment Management
Georgia
$155K +$13.9K +65 +10%
DTL
50
Dynamic Technology Lab
Singapore
$154K +$155K +722 New
1
2
3 4

CRBP Hedge Fund Activity: Q4 2017 in Review

88 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q4 2017, worth a combined $150M — up 38% from $109M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CRBP positions and 7 closed out — a net gain of 20 holders — while 33 added to existing stakes and 16 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $9.63M. The largest seller was Millennium Management, cutting an estimated $2.11M.

  • 88 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q4 2017, up from 69 in Q3 2017.
  • Funds reported $150M of Corbus Pharmaceuticals stock for Q4 2017, up 38% quarter-over-quarter.
  • 27 funds opened new Corbus Pharmaceuticals positions in Q4 2017 and 7 closed out, a net change of +20 holders.
  • The largest Corbus Pharmaceuticals buyer in Q4 2017 was Fidelity Investments, an estimated $9.63M added.
  • The largest Corbus Pharmaceuticals seller in Q4 2017 was Millennium Management, an estimated $2.11M sold.

Based on aggregated 13F filings for Q4 2017.